Your browser doesn't support javascript.
loading
Continuation or maintenance ECT for schizophrenia: A narrative review of case report data.
Egan, Olivia; Talbot, Daniel; Mayur, Prashanth; Harris, Anthony.
Affiliation
  • Egan O; Westmead Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Talbot D; Western Sydney Local Health District, Westmead, NSW, Australia; and Specialty of Psychiatry, Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW, Australia.
  • Mayur P; Western Sydney Local Health District, Westmead, NSW, Australia; and Specialty of Psychiatry, Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW, Australia.
  • Harris A; Western Sydney Local Health District, Westmead, NSW, Australia; Specialty of Psychiatry, Sydney Medical School, Faculty of Medicine and Health Sciences, University of Sydney, Sydney, NSW, Australia; and Brain Dynamics Centre, Westmead Institute for Medical Research, Westmead, NSW, Australia.
Australas Psychiatry ; 32(4): 309-313, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38805612
ABSTRACT

OBJECTIVE:

This review aimed to address the limited evidence on the efficacy of continuation or maintenance electroconvulsive therapy (C/M-ECT) in schizophrenia, with a focus on international case reports and series due to the scarcity of randomised controlled trials. MATERIALS AND

METHODS:

Electronic database searches were conducted to identify case reports or series evaluating the efficacy of C/M-ECT in patients with schizophrenia or schizoaffective disorder.

RESULTS:

C/M-ECT treatment span varied from 3 months to 36 years (Median = 30 months; M = 43.9 months; SD = 63.0) and was effective in maintaining remission for most patients with schizophrenia in combination with antipsychotic medication. Reporting of adverse events including cognitive adverse effects was infrequent.

CONCLUSIONS:

Collation of case reports and series data indicated that C/M-ECT, when combined with antipsychotics, appears to be a safe and effective strategy for maintaining remission, even over several years. Caution is warranted due to the potential influence of publication bias.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Electroconvulsive Therapy Limits: Humans Language: En Journal: Australas Psychiatry Journal subject: PSIQUIATRIA Year: 2024 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Electroconvulsive Therapy Limits: Humans Language: En Journal: Australas Psychiatry Journal subject: PSIQUIATRIA Year: 2024 Type: Article Affiliation country: Australia